Concepedia

Hayley S. McLoughlin

HS

18

Publications

832

Citations

16

H-Index

2012

Active since

Affiliations

University of Michigan(Current)

University of Minnesota

Ionis Pharmaceuticals (United States)

National Institutes of Health

University of Iowa

Hayley S. McLoughlin is an author at University of Michigan specializing in medicine, cell biology, and neurodegenerative diseases.

ORCID

Top concepts

Publications per year

2012–2024

18

Publications

18

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice

Hayley S. McLoughlin, Lauren R. Moore, Ravi Chopra et al. · Annals of Neurology · 2018 · 154 citations · Full text

Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models

Lauren R. Moore, Gautam Rajpal, Ian T. Dillingham et al. · Molecular Therapy — Nucleic Acids · 2017 · 137 citations · Full text

, , +17

Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis

S Wade, Nils Ohnesorge, Hayley S. McLoughlin et al. · EBioMedicine · 2019 · 75 citations · Full text

Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis

Hayley S. McLoughlin, Sarah K. Fineberg, Laboni Ghosh et al. · Neuroscience · 2012 · 74 citations

, , +4

Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3

Mercedes Prudencio, Héctor García‐Moreno, Karen Jansen‐West et al. · Science Translational Medicine · 2020 · 50 citations · Full text

Rows per page

1–5 of 18